FDA inspection
Havix Group Inc d/b/a Aavis Pharmaceuticals: FDA inspection ending Apr 19, 2022
FDA inspection 1167386 · Voluntary Action Indicated (VAI) · Hoschton, GA
Key facts
| Inspection ID | 1167386 |
|---|---|
| Firm | Havix Group Inc d/b/a Aavis Pharmaceuticals |
| FEI number | 3012841169 |
| Address | 9488 Jackson Trail Rd Ste A |
| City | Hoschton |
| State | GA |
| ZIP | 30548-2491 |
| Fiscal year | 2022 |
| Inspection end date | Apr 19, 2022 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data